Design and evaluation of matrix diffusion controlled transdermal patches of Diltiazem hydrochloride;Diseño y evaluación de matrices de difusión controlada en parches transdérmicos de clorhidrato de Diltiazem

Ars Pharmaceutica

Volumn 49, Issue 3, 2008, Pages 211-227

  Prabu, S Lakshmana ^a   Shirwaikar, A A ^a   Shirwaikar, Annie ^a   Kumar, Aravind ^a   Jacob, Abraham ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Diltiazem hydrochloride; Eudragit RL PM; Polyvinyl pyrrolidone; Release studies; Rosin; Transdermal patch

Indexed keywords

CAMPHOR; DILTIAZEM; EUDRAGIT; EUDRAGIT RL PM; POVIDONE; ROSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; ISOLATED ORGAN; NONHUMAN; RABBIT; RAT; SKIN PENETRATION; TRANSDERMAL PATCH;

EID: 58949097899     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ghosh TK, Pfister WF. Transdermal and Topical Delivery Systems: An overview and future trends. In: Ghosh TK, Pfister WF (ed.) Transdermal and Topical Drug Delivery Systems, CRC Press, Boca Raton, FL, 1997; p. 1-32.
2. Verma PRP, Iyer SS. Transdermal delivery of propranolol using mixed grades of Eudragit: Design and in vitro and in vivo evaluation Drug Dev Ind Pharm 2000; 26(4): 471-476.
3. Hadgraft J, Guy RH. Selection of drug candidates for transdermal delivery. In: Transdermal Drug Delivery, 1st ed., Marcel Dekker Inc., New York, 1989; p.60-120.
4. Devi VK, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 2003; 29(5): 495-503.
5. Chaffman M, Brogden RN. Diltiazem: A review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29(5): 387-454.
6. Kim H, Fassihi R. New ternary polymeric matrix system for control drug delivery of highly soluble drugs. Pharm Res 1997; 14: 1415-1421.
7. Sheorey DS, Dorle AK. Preparation and study of release kinetics of rosin pentaerythritol ester microcapsules. J. Microen 1994; 11(1): 11-17.
8. Shirwaikar AA, Reddy N. Rosin, a polymer for micro encapsulation of Diltiazem Hydrochloride for sustained release by emulsion solvent evaporation technique. Ind J Pharm Sci 2000; 62(4): 308-310.
9. Pathak YV, Dorle AK. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs, Drug Dev Ind Pharm 1990; 6(3): 223-227.
10. Ramani CC, Puranik PK, Dorle AK. Study of maleoabietic acid as matrix forming material. Int J Pharm 1996; 1: 344-352.
11. Satturwar PM, Fulzele SV, Mandaogade PM, Mundhada DR, Gogte BB, Dorle AK. Evaluation of new rosin derivative for pharmaceutical coating. Int J Pharm 2004; 270 (1-2): 27-36.
12. Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel film forming polymer for drug delivery. Int. J. Pharm 2002; 249(1-2): 175-184.
13. Satturwar PM, Fulzele SV, Dorle AK. Evaluation of polymerized rosin for the formulationand evelopment of transdermal drug delivery system. A technical note. AAPSPharmSciTech, 2005; 6(4): article 81.
14. Balestrieri, F, Magri, AD, Magri AL, Marini D, Sacchini A. Application of differential scanning calorimetry to the study of drug-excipient compatibility. Thermochimica Acta 1996; 285: 337-345.
15. British Pharmacopoeia Commission. British Pharmacopoeia. Addendum 1996. London, UK: British Pharmacopoeia Commission; 1996; 1761.
16. Rao PR, Ramakrishna S, Diwan PV. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm Dev Techno 2000; l5: 465-472.